LPTX Leap Therapeutics Inc

Leap Therapeutics Inc is a biopharmaceutical company . The Company is engaged in acquiring and developing novel therapeutics at the leading edge of cancer biology.

$2.34
As of 03/02/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
01/25/2017
59,657,742
968,583
$144,968,313
0.00%
SEC Edgar Online
10-Q
10-K
52187K101
US52187K1016
BYNS707

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-4.69
2.73
128.86
-54.20%
-2,560.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy